Sabra Net Income Applicable To Common Shares from 2010 to 2026

SBC Stock  EUR 17.33  0.36  2.12%   
Sabra Health's Net Loss is decreasing over the last several years with slightly volatile swings. Net Loss is estimated to finish at about -66.4 M this year. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-69.8 M
Current Value
-66.4 M
Quarterly Volatility
101.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Sabra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Health's main balance sheet or income statement drivers, such as Interest Expense of 101.1 M, Selling General Administrative of 41.5 M or Total Revenue of 645.7 M, as well as many indicators such as . Sabra financial statements analysis is a perfect complement when working with Sabra Health Valuation or Volatility modules.
  
This module can also supplement various Sabra Health Technical models . Check out the analysis of Sabra Health Correlation against competitors.
The Net Income Applicable To Common Shares trend for Sabra Health Care offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Sabra Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Sabra Health's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Sabra Health Care over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Sabra Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sabra Health's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Sabra Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean33,108,131
Geometric Mean80,728,389
Coefficient Of Variation306.88
Mean Deviation80,107,831
Median60,034,000
Standard Deviation101,601,229
Sample Variance10322.8T
Range382.6M
R-Value(0.54)
Mean Square Error7808.5T
R-Squared0.29
Significance0.03
Slope(10,850,671)
Total Sum of Squares165165T

Sabra Net Income Applicable To Common Shares History

2026-66.4 M
2025-69.8 M
2022-77.6 M
2021-113.3 M
2020138.4 M
201969 M
2018269.3 M

About Sabra Health Financial Statements

Sabra Health stakeholders use historical fundamental indicators, such as Sabra Health's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Sabra Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Health's assets and liabilities are reflected in the revenues and expenses on Sabra Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Health Care. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-69.8 M-66.4 M

Currently Active Assets on Macroaxis

Other Information on Investing in Sabra Stock

Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.